Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Infrared Spectroscopy in Septic Arthritis Diagnosis (SynoFAST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02860871
Recruitment Status : Completed
First Posted : August 9, 2016
Last Update Posted : April 25, 2017
Sponsor:
Information provided by (Responsible Party):
Rennes University Hospital

Brief Summary:
The main objective of this study is to assess the ability of Fiber-optic Evanescent Wave Spectroscopy (FEWS) to discriminate synovial fluids samples of septic arthritis patients from other causes of joint effusion by analyzing ex vivo joint fluid samples collected during routine clinical care.

Condition or disease Intervention/treatment
Joint Effusion Other: infrared spectroscopy

Layout table for study information
Study Type : Observational
Actual Enrollment : 611 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Use of Infrared Spectroscopy in Septic Arthritis Diagnosis
Study Start Date : June 2014
Actual Primary Completion Date : August 2016
Actual Study Completion Date : December 2016

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Diagnosis of the cause of joint effusion [ Time Frame: through study completion, an average of 6 months ]
    The final diagnosis of the cause of joint effusion is made by the clinician based on the clinical and laboratory data : septic arthritis or other causes of arthritis.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients benefiting from joint fluid puncture for diagnostic purposes in the rheumatology hospitals participating in the study
Criteria

Inclusion Criteria:

  • patients benefiting from joint fluid puncture for diagnostic purposes in the rheumatology hospitals participating in the study
  • patients over 18 year old,
  • patients who received information about the protocol and have not expressed opposition to participate.

Exclusion Criteria:

  • patients opposing the study,
  • patients aged below 18 year old
  • Protected major (safeguard justice , trusteeship and guardianship) and persons deprived of liberty

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02860871


Locations
Layout table for location information
France
CHU de RENNES
Rennes, France, 35033
Sponsors and Collaborators
Rennes University Hospital

Layout table for additonal information
Responsible Party: Rennes University Hospital
ClinicalTrials.gov Identifier: NCT02860871     History of Changes
Other Study ID Numbers: 35RC13_8815
First Posted: August 9, 2016    Key Record Dates
Last Update Posted: April 25, 2017
Last Verified: July 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Arthritis, Infectious
Arthritis
Joint Diseases
Musculoskeletal Diseases
Infection